Biceps Tendon Disorder Clinical Trial
Official title:
Post-market Clinical Follow-up Study to Provide Safety, Performance and Clinical Benefits Data of the ToggleLoc™ 2.9mm and the JuggerLoc™ Soft Tissue Systems (Implants and Instrumentation) in the Shoulder - A Multicenter Retrospective Study
Verified date | April 2023 |
Source | Zimmer Biomet |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The study is a multicenter, retrospective, non-randomized, non-controlled and consecutive series post-market study. The purpose of this study is to collect data confirming safety, performance and clinical benefits of the ToggleLoc 2.9 mm and the JuggerLoc Soft Tissue Systems when used for soft tissue to bone fixation in the shoulder. The primary objective is the assessment of performance by analyzing soft tissue to bone healing in the shoulder. The secondary objective is the assessment of safety and clinical benefits. Safety will be evaluated by recording and analyzing the incidence and frequency of complications and adverse events. Relation of the events to device, instrumentation and/or procedure will be specified. Clinical benefits will be assessed by recording patient-reported outcome measures (PROMs) at the longest follow-up after surgery (minimum one year).
Status | Enrolling by invitation |
Enrollment | 206 |
Est. completion date | June 30, 2024 |
Est. primary completion date | June 30, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients that received the ToggleLoc 2.9 mm and/or the JuggerLoc Soft Tissue devices for soft tissue to bone fixation in the shoulder. - Patients 18 years or older and skeletally mature. - Patients capable of understanding the surgeon's explanations and following his/her instructions, able and willing to participate in the follow-up program and who gave consent to take part in the study. Exclusion Criteria: - Infection. - Patient conditions including blood supply limitations, and insufficient quantity or quality of bone or soft tissue. - Patients with mental or neurologic conditions who are unwilling or incapable of following postoperative care instructions. - Foreign body sensitivity. Where material sensitivity is suspected, testing is to be completed prior to implantation of the device. - Patients who are unwilling or unable to give consent, or to comply with the follow-up program. - Patients who have any condition that would in the judgment of the Investigator place the patient at undue risk or interfere with the study. - Patient is a vulnerable subject (prisoner, mentally incompetent or unable to understand what participation to the study entails, a known alcohol or drug abuser, anticipated to be non-compliant). - Off-label use. |
Country | Name | City | State |
---|---|---|---|
Spain | Centro Médico Quirónsalud | Alicante | |
Spain | Hospital Universitario Quirónsalud | Madrid | |
United States | Advanced Bone and Joint | Saint Peters | Missouri |
Lead Sponsor | Collaborator |
---|---|
Zimmer Biomet |
United States, Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Soft tissue to bone healing in the shoulder | Assessment of performance by analyzing soft tissue to bone healing in the shoulder. The principal investigator will clinically evaluate the study shoulder to assess if soft tissue to bone healing has occurred using a assessment of pain. Pain will be measured from none (no pain) to severe. | From operation to the study completion, minimum 1 year post-op. | |
Secondary | Incidence of revisions | Safety will be evaluated by recording and analyzing the incidence of revisions. A Kaplan Meier survival curve will be calculated. The Kaplan-Meier involves computing of probabilities of occurrence of revision at a certain point of time. | From operation to the study completion, minimum 1 year post-op. | |
Secondary | EuroQol five-dimensional Health Questionnaire (EQ-5D-5L) | Clinical benefits will be assessed by recording patient-reported outcome measures (PROMs). The EuroQol five-dimensional Health Questionnaire (EQ-5D-5L): is a generic instrument. The EQ is scored on a 0 to 100 mm scale representing "the worst..." and "the best health you can imagine", respectively. | From pre-operative to the study completion, minimum 1 year post-op. | |
Secondary | Oxford Shoulder Score (OSS) | Clinical benefits will be assessed by recording patient-reported outcome measures (PROMs). the Oxford Shoulder Score (OSS) is a 12-item, each with 5 potential answers specifically designed and developed for assessing outcomes of shoulder surgery. The score will be on a scale from 0 (worst) to 48 (best). | From pre-operative to the study completion, minimum 1 year post-op. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT04073212 -
Dry Needling and Exercise Versus Traditional Physical Therapy for Biceps Tendinitis
|
N/A | |
Active, not recruiting |
NCT05519228 -
PMCF Study on the Safety, Performance and Clinical Benefits Data of the ToggleLoc™ 2.9mm in the Elbow
|
||
Terminated |
NCT03529162 -
A Prospective Study Comparing Suture Anchor and Soft Tissue Pectoralis Major Tendon Techniques for Biceps Tenodesis
|
N/A | |
Recruiting |
NCT05370183 -
Tenotomy of Biceps' Long Head by Mini-optics in Consultation (Hyperambulatory): What Advantage Compared to the Operating Room?
|
N/A | |
Recruiting |
NCT06446336 -
Creation of a Pre-operative Score, the HASS Score, for Injuries Reliable Diagnosis of Long Biceps Tendon
|
||
Completed |
NCT04650477 -
Forearm Position in Subpectoral Biceps Tenodesis
|
N/A |